Effects of GnRH agonist for luteal support on improvement of intracytoplasmic sperm injection cycles
Phase 2
- Conditions
- oninflammatory disorders of female genital tract.Complication associated with artificial fertilization, unspecified
- Registration Number
- IRCT2016101729027N2
- Lead Sponsor
- Vice Chancellor for research of Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 240
Inclusion Criteria
Age between 20-38; Body mass index (BMI) between 20-30; fresh embryo transfer cycles; 3rd menstrual day serum FSH below 10; absence of low ovarian response according Bologna Criteria Exclusion criteria: unwillingness to continue; absence of good quality embryo; ovarian hyper stimulation (more than 18 mature follicle during ovarian stimulation)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Serum BHCG.
- Secondary Outcome Measures
Name Time Method Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Fetal heart beat in ultrasound.;Abortion. Timepoint: Before 20 weeks of pregnancy. Method of measurement: Fetal demise before 20 weeks of gestation.